Buy CryptoMarketsSpotFuturesGOLDEarnEvent Center
More
Gold vs Crypto
Oncotelic Therapeutics subsidiary Sapu Nano to present its Deciparticle nanomedicine platform and clinical pipeline at BIO-Europe Spring 2026, seeking partnershipsOncotelic Therapeutics subsidiary Sapu Nano to present its Deciparticle nanomedicine platform and clinical pipeline at BIO-Europe Spring 2026, seeking partnerships

Oncotelic’s Sapu Nano to Showcase Deciparticle Nanomedicine Platform at BIO-Europe Spring 2026

Author: Citybuzz
Source: Citybuzz
2026/03/24 21:35
2 min read
BIO Protocol
BIO$0.01791-2.55%
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Oncotelic Therapeutics, Inc. (OTCQB: OTLC) announced that its subsidiary Sapu Nano will present its Deciparticle nanomedicine platform and clinical pipeline at BIO-Europe Spring 2026 on March 25, where it has been selected as a presenting company. The presentation will highlight the company’s next-generation drug delivery technology designed to improve therapeutic outcomes in oncology.

The company will showcase two lead candidates during the event. Sapu003 (Everolimus for Injection) is currently in Phase 1 clinical trials, while Sapu006 (Docetaxel for Injection) is entering Phase 1 studies. These developments represent significant steps in advancing nanomedicine applications for cancer treatment.

Oncotelic’s participation in BIO-Europe Spring 2026 comes as the company seeks strategic partnerships to advance development and commercialization of its technologies. The event serves as a platform for biotechnology companies to connect with potential partners and investors in the life sciences sector.

The company’s focus on improving drug delivery through nanotechnology has implications for enhancing therapeutic index and unlocking new clinical potential for established cancer treatments. This approach could potentially address limitations in current drug delivery methods and improve patient outcomes in oncology.

For investors seeking additional information about Oncotelic Therapeutics, the company maintains a newsroom at https://ibn.fm/OTLC where updates are regularly posted. The full press release announcing the BIO-Europe Spring 2026 presentation is available at https://ibn.fm/Slq47.

The presentation at BIO-Europe Spring 2026 represents an important opportunity for Oncotelic to demonstrate the potential of its Deciparticle platform to the international biotechnology community. As the company advances its clinical pipeline, this visibility could facilitate partnerships necessary for further development and eventual commercialization of its nanomedicine technologies.

Blockchain Registration, Verification & Enhancement provided by NewsRamp™

This news story relied on content distributed by InvestorBrandNetwork (IBN). Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Oncotelic’s Sapu Nano to Showcase Deciparticle Nanomedicine Platform at BIO-Europe Spring 2026.

The post Oncotelic’s Sapu Nano to Showcase Deciparticle Nanomedicine Platform at BIO-Europe Spring 2026 appeared first on citybuzz.

Market Opportunity
BIO Protocol Logo
BIO Protocol Price(BIO)
$0.01791
$0.01791$0.01791
-1.64%
USD
BIO Protocol (BIO) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Why It Could Outperform Pepe Coin And Tron With Over $7m Already Raised

Why It Could Outperform Pepe Coin And Tron With Over $7m Already Raised

The post Why It Could Outperform Pepe Coin And Tron With Over $7m Already Raised appeared on BitcoinEthereumNews.com. Crypto News 17 September 2025 | 20:26 While meme tokens like Pepe Coin and established networks such as Tron attract headlines, many investors are now searching for projects that combine innovation, revenue-sharing and real-world utility. BlockchainFX ($BFX), currently in presale at $0.024 ahead of an expected $0.05 launch, is quickly becoming one of the best cryptos to buy today. With $7m already secured and a unique model spanning multiple asset classes, it is positioning itself as a decentralised super app and a contender to surpass older altcoins. Early Presale Pricing Creates A Rare Entry Point BlockchainFX’s presale pricing structure has been designed to reward early participants. At $0.024, buyers secure a lower entry price than later rounds, locking in a cost basis more than 50% below the projected $0.05 launch price. As sales continue to climb beyond $7m, each new stage automatically increases the token price. This built-in mechanism creates a clear advantage for early investors and explains why the project is increasingly cited in “best presales to buy now” discussions across the crypto space. High-Yield Staking Model Shares Platform Revenue Beyond its presale appeal, BlockchainFX is creating a high-yield staking model that gives holders a direct share of platform revenue. Every time a trade occurs on its platform, 70% of trading fees flow back into the $BFX ecosystem: 50% of collected fees are automatically distributed to stakers in both BFX and USDT. 20% is allocated to daily buybacks of $BFX, adding demand and price support. Half of the bought-back tokens are permanently burned, steadily reducing supply. Rewards are based on the size of each member’s BFX holdings and capped at $25,000 USDT per day to ensure sustainability. This structure transforms token ownership from a speculative bet into an income-generating position, a rare feature among today’s altcoins. A Multi-Asset Platform…
Share
BitcoinEthereumNews2025/09/18 03:35
Trump sets stage for a 'post-America world': NYT reporter

Trump sets stage for a 'post-America world': NYT reporter

When Joe Biden was elected president, he frequently asserted that “America was back” and collaborating with allies again. But the fact that the United States would
Share
Alternet2026/03/24 23:03
Forward Industries zet $4 miljard in om Solana bezit uit te breiden

Forward Industries zet $4 miljard in om Solana bezit uit te breiden

Forward Industries gooit het roer om met een flinke financiële zet: het bedrijf lanceert een zogeheten “At The Market” aandelenprogramma van maar liefst $4 miljard. Het programma geeft het bedrijf flexibiliteit om op elk gewenst moment aandelen te verkopen, wat vooral handig is voor het uitbreiden van hun Solana treasury... Het bericht Forward Industries zet $4 miljard in om Solana bezit uit te breiden verscheen het eerst op Blockchain Stories.
Share
Coinstats2025/09/18 01:31